Research Article
miR-1291 Functions as a Potential Serum Biomarker for Bullous Pemphigoid
Table 3
Characteristics of the 13 BP patients whose serum samples were collected in both the disease active and control stages.
| | BP patients () |
| | Age (years) median (IQR) | 57 (51-71.5) | | Sex (female/male) | 7/6 | | Female age (years) median (IQR) | 56 (46-62) | | Male age (years) median (IQR) | 71.5 (51.5-79.25) | | Disease duration (months) median (IQR) | 2 (1-3.5) | | Previous history, (%) | 5 (38.5) | | Hypertension, (%) | 4 (30.8) | | Cerebrovascular disease, (%) | 2 (15.4) | | miR-1291 (2-ΔCt), median (IQR), | | | Baseline | 0.74 (0.28-2.66) | | Disease control stage | 0.19 (0.08-0.50) | | CCL17 (pg/mL) median (IQR), | | | Baseline | 1557 (387-5906) | | Disease control stage | 246.3 (86.4-514.2) | | , median (IQR), | | | Baseline | 103.5 (66.08-168.2) | | Disease control stage | 18.09 (4.80-48.58) | | , median (IQR), | | | Baseline | 80.87 (27.32-102.9) | | Disease control stage | 21.61 (2.65-59.63) |
|
|
